Pharmaceutical

Orano Med unveils radiopharma manufacturing plant in In...

The facility is expected to allow Orano Med to produce 5,000 doses of lead-212 b...

FDA AdCom to question efficacy and safety concerns with...

The FDA is looking to ask questions about a change of primary endpoint, treatmen...

Agomab wins FDA orphan drug status for idiopathic pulmo...

Agomab Therapeutics has now secured a US Food and Drug Administration (FDA) orph...

Ukraine: a market access review over two years of war

GlobalData compares how market access to healthcare in Ukraine has changed durin...

Avadel Pharmaceuticals gets grant for patent granted fo...

Discover Avadel Pharmaceuticals' innovative patent for modified release formulat...

J&J seeks expanded approvals for paediatric HIV-1 therapy

Johnson & Johnson has sought approval from the US FDA for the use of its HIV-1 t...

AstraZeneca completes Fusion Pharmaceuticals acquisition

AstraZeneca has announced the conclusion of its acquisition of clinical-stage bi...

Climate change may aggravate multiple sclerosis

A June 2024 literature review has revealed that climate change has the potential...

Bluejay touts positive data for chronic hepatitis D tre...

The biopharma shared preliminary Phase II data at EASL for its IgG1 monoclonal a...

Scientists push for ‘greener’ drugs in published study

5 June marks World Environment Day, an annual celebration that encourages global...

FDA hearing set to discuss advisory committee members’ ...

FDA officials outline what to expect at the upcoming hearing on AdComs, and elab...

Bio-Sourcing and Afrigen Biologics partner on biomanufa...

Belgian biotech, Bio-Sourcing, and Cape Town based company, Afrigen Biologics, h...

Be Bio’s haemophilia B treatment gains FDA orphan drug ...

The US FDA has granted orphan drug designation to Be Biopharma’s (Be Bio) BE-101...

MDMA therapy wait goes on as FDA panel rejects Lykos’ P...

An FDA advisory committee, whilst noting improvement in patient symptoms, was no...

AbbVie’s RINVOQ now indicated for paediatric arthritis ...

AbbVie's RINVOQ is now indicated for polyarticular juvenile idiopathic arthritis...

FDA approves Moderna’s RSV vaccine mRESVIA

Moderna has secured approval from the US Food and Drug Administration (FDA) for ...